These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 19300443)

  • 1. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors.
    Kutner RH; Zhang XY; Reiser J
    Nat Protoc; 2009; 4(4):495-505. PubMed ID: 19300443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of lentiviral vectors in protein-free media.
    Kuroda H; Marino MP; Kutner RH; Reiser J
    Curr Protoc Cell Biol; 2011 Mar; Chapter 26():Unit 26.8. PubMed ID: 21400699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and concentration of pseudotyped HIV-1-based gene transfer vectors.
    Reiser J
    Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.
    Kutner RH; Puthli S; Marino MP; Reiser J
    BMC Biotechnol; 2009 Feb; 9():10. PubMed ID: 19220915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of High-Titer Pseudotyped Lentiviral Vectors.
    Hu S; Li M; Akkina R
    Methods Mol Biol; 2019; 1937():125-134. PubMed ID: 30706393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the titer and infectivity of lentiviral vectors.
    Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB
    Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation.
    Papanikolaou E; Kontostathi G; Drakopoulou E; Georgomanoli M; Stamateris E; Vougas K; Vlahou A; Maloy A; Ware M; Anagnou NP
    Virus Res; 2013 Jul; 175(1):1-11. PubMed ID: 23583684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upscaling of lentiviral vector production by tangential flow filtration.
    Geraerts M; Michiels M; Baekelandt V; Debyser Z; Gijsbers R
    J Gene Med; 2005 Oct; 7(10):1299-310. PubMed ID: 15906396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
    Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
    Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of HIV-1-based lentiviral vector particles.
    Ramezani A; Hawley RG
    Curr Protoc Mol Biol; 2002 Nov; Chapter 16():Unit 16.22. PubMed ID: 18265303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
    Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
    Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
    Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
    Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
    Kuroda H; Kutner RH; Bazan NG; Reiser J
    J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
    Beyer WR; Westphal M; Ostertag W; von Laer D
    J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of multicistronic HIV-1 based lentiviral vectors.
    Chinnasamy N; Shaffer J; Chinnasamy D
    Methods Mol Biol; 2009; 515():137-50. PubMed ID: 19378113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
    Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
    J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.